Gossamer Bio (GOSS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Gossamer Bio (GOSS) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.23 of bullish evidence against -0.47 bearish.

Gossamer Bio last closed at $10.65, -0.56% on the session.

Against the IVW growth benchmark the position is -1.48% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

16 graded predictions for GOSS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Gossamer Bio in the 96th percentile on return on equity, where 100 is best.

Gossamer Bio is classified under Health Care / Biotechnology, with a market capitalisation of $65.50M.

StockMap tracks Gossamer Bio as the 274th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Gossamer Bio ranks 269th of 344 in the group, against a group median of -0.21.